as on September 18, 2025 at 1:29 am IST
Day's Low
Day's High
2.83%
Downside
2.83%
Upside
52 Week's Low
52 Week's High
23.58%
Downside
98.11%
Upside
Check Enlivex Therapeutics Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$25.9M
EPS (TTM)
-0.515
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0P/B Ratio
0PEG Ratio
0EBITDA
-14.8M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
189710700.00%
Compare market cap, revenue, PE, and other key metrics of Enlivex Therapeutics Ltd with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $25.9M | -79.31% | NA | 0.00% | |
BUY | $60.5B | 252.04% | -505.15 | -12.96% | |
NA | $39.0B | NA | NA | -3.89% | |
BUY | $100.3B | 44.17% | 27.85 | 31.86% | |
BUY | $59.6B | 1.78% | 14.1 | 31.37% |
The Enlivex Therapeutics Ltd stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Enlivex Therapeutics Ltd investment value today
Current value as on today
₹74,797
Returns
Returns from Enlivex Therapeutics Ltd Stock
Dollar Returns*
₹4,598 (+4.6%)
Based on 7 analysts
85.71%
Buy
14.29%
Hold
0.00%
Sell
Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Enlivex Therapeutics Ltd. Average target price of $10
Get share price movements and forecasts by analysts on Enlivex Therapeutics Ltd.
What analysts predicted
89.4%UPSIDE
Target Price
$10
Current Price
$1.06
Analyzed by
7 Analysts
Target
$10.00
Enlivex Therapeutics Ltd target price $10, a slight upside of 89.4% compared to current price of $1.06. According to 7 analysts rating.
Search interest for Enlivex Therapeutics Ltd Stock has decreased by -7% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 68.9% return, outperforming this stock by 99.2%
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 194.1%
Price Dip
In the last 1 month, ENLV stock has moved down by -13.6%
Organisation | Enlivex Therapeutics Ltd |
Headquarters | 14 Einstein Street, Ness Ziona, Israel, 7403618 |
Industry | Biotechnology |
CEO | Dr. Oren Hershkovitz Ph.D. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Ms. Shachar Shlosberger CPA | Chief Financial Officer |
Dr. Veronique Amor-Baroukh | Senior Director of Operations |
Ms. Sigal Arad | Director of Human Resources |
Dr. Einat Galamidi M.D. | Chief Medical Officer |
Mr. Shai Novik M.B.A. | Executive Chairman |
Dr. Oren Hershkovitz Ph.D. | Chief Executive Officer |
Prof. Dror Mevorach M.D. | Founder & Scientific Advisor |
Enlivex Therapeutics Ltd share price today is $1.06 as on at the close of the market. Enlivex Therapeutics Ltd share today touched a day high of $1.09 and a low of $1.03.
Enlivex Therapeutics Ltd share touched a 52 week high of $2.1 on and a 52 week low of $0.81 on . Enlivex Therapeutics Ltd stock price today i.e. is closed at $1.06,which is 49.52% down from its 52 week high and 30.85% up from its 52 week low.
Enlivex Therapeutics Ltd market capitalisation is $0.00T as on .
Indian investors can start investing in Enlivex Therapeutics Ltd (ENLV) shares with as little as ₹87.816 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Enlivex Therapeutics Ltd stock (as per the Rupee-Dollar exchange rate as on ).
Based on Enlivex Therapeutics Ltd share’s latest price of $1.06 as on September 18, 2025 at 1:29 am IST, you will get 9.4340 shares of Enlivex Therapeutics Ltd. Learn more about
fractional shares .
Enlivex Therapeutics Ltd stock has given -79.31% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?